Search Results

0 results for ''Seeger Weiss''

You can use to get even better search results
Goodwin Procter Persuades Judge to Reject Countrywide Class Action for the Second Time
Publication Date: 2011-12-19
Practice Area:
Industry:
Court:
Judge:
Attorneys:
For plaintiff:
For defendant:
Case number:

Federal district court judge Dana Sabraw on Friday refused to certify a proposed class of 60,000 California home-loan borrowers who were allegedly misled by Countrywide's sales and marketing practices. Relying on the same reasoning that he used when rejecting a larger class in October, Sabraw ruled that the plaintiffs had failed to meet the commonality test in the U.S. Supreme Court's Dukes decision.

September 20, 2007 |

Attorney Ineligibility Order Pursuant to Rule 1:28-2(a)

Notice to the bar.
400 minute read
April 28, 2010 |

A second award in Chinese drywall litigation

A New Orleans federal district judge has awarded $164,000 in damages to a family whose home was deemed uninhabitable because of defective Chinese drywall.
2 minute read
Another Judge Prods Plaintiffs Lawyers on Diversity
Publication Date: 2013-05-20
Practice Area:
Industry:
Court:
Judge:
Attorneys:
For plaintiff:
For defendant:
Case number:

For years U.S. District Judge Harold Baer in Manhattan has been using his power to appoint plaintiffs counsel as a means to cajole lawyers to find more women and minorities to lead class action lawsuits. Now another New York judge has followed his lead in a suit against Bayer AG.

Public Citizen Out in Crucial Supreme Court Drug Pre-emption Case
Publication Date: 2008-08-14
Practice Area:
Industry:
Court:
Judge:
Attorneys:
For plaintiff:
For defendant:
Case number:

In re: Bernard L. Madoff Investment Securities LLC, 10-2378-bk(L)
Publication Date: 2011-08-17
Practice Area: Bankruptcy
Industry:
Court: U.S. Court of Appeals, Second Circuit
Judge: Before: Jacobs, Chief Judge, Leval and Raggi, Circuit Judges.
Attorneys:
For plaintiff: HELEN DAVIS CHAITMAN, Becker & Poliakoff, LLP, New York, New York (Peter Schuyler, on the brief), for Appellants Diane and Roger Peskin, et al.
For defendant:
Case number: 10-2378-bk(L)

Cite as: In re: Bernard L. Madoff Investment Securities LLC, 10-2378-bk, NYLJ 1202511400493, at *1 (2d Cir., Decided August 16, 2011)Before: Jacobs, Chief

Roche Loses $25 Million Jury Verdict in Accutane Retrial
Publication Date: 2010-02-17
Practice Area:
Industry:
Court:
Judge:
Attorneys:
For plaintiff:
For defendant:
Case number:

The first time around, Andrew McCarrell won a $2.7 million verdict against the drug company, which he claimed was responsible for causing his debilitating bowel disease. Roche succeeded in overturning the verdict--only to get hit with a much, much worse result.

Missouri Jury Concludes Hog Farms Smell Bad, Awards $11 Million to Neighbors
Publication Date: 2010-03-08
Practice Area:
Industry:
Court:
Judge:
Attorneys:
For plaintiff:
For defendant:
Case number:

For the third time in recent years, a Missouri state court jury has hit Premium Standard Farms with a multimillion-dollar verdict, finding the odor of its hog farms is a public nuisance. Premium Standard, meanwhile, says it doesn't smell anything--and is threatening economic consequences for neighborhoods where it's not welcome.

October 05, 2005 |

Keen Questioning by Jurors Demystifies Vioxx Trial

Whatever the outcome of the first New Jersey Vioxx trial, lawyers on both sides are less likely to be surprised than they were over the $253 million verdict in Texas against Merck & Co. That's because Judge Carol Higbee is letting jurors question witnesses. For the lawyers in the case, juror questions are sources of early feedback. And since the trial is being covered live by Court TV Extra, it's becoming an educational laboratory for lawyers on both sides of mass tort cases nationwide.
8 minute read
February 19, 2010 |

Latest Accutane Trial Ends With a $25 Million Loss for Roche

An Atlantic City, N.J., jury has socked Swiss pharmaceutical giant Roche Holding AG with another big verdict involving its potent acne medication, Accutane, this one to the tune of $25.16 million.
2 minute read

TRENDING STORIES

    Resources